Mansoor Mirza (@mirzacph) 's Twitter Profile
Mansoor Mirza

@mirzacph

ID: 729294624926380032

calendar_today08-05-2016 12:59:23

34 Tweet

288 Followers

8 Following

NSGO_org (@nsgo_org) 's Twitter Profile Photo

𝐄𝐍𝐆𝐎𝐓, 𝐍𝐒𝐆𝐎-𝐂𝐓𝐔 & 𝐆𝐎𝐆 𝐩𝐫𝐨𝐮𝐝𝐥𝐲 𝐚𝐧𝐧𝐨𝐮𝐧𝐜𝐞 𝐭𝐡𝐞 𝐠𝐫𝐨𝐮𝐧𝐝-𝐛𝐫𝐞𝐚𝐤𝐢𝐧𝐠 𝐫𝐞𝐬𝐮𝐥𝐭𝐬 𝐨𝐟 𝐄𝐍𝐆𝐎𝐓-𝐄𝐍6-𝐍𝐒𝐆𝐎/𝐆𝐎𝐆-3031/𝐑𝐔𝐁𝐘 𝐭𝐫𝐢𝐚𝐥. rb.gy/sqxq7u #Endometrial #Cancer #RUBY #NSGO #ENGOT #Dostarlimab #ESMO #SGO

Ane Gerda Z Eriksson MD PhD (@agz_eriksson) 's Twitter Profile Photo

Mansoor Mirza presenting practice changing Ruby trial results at #SGOmtg ✅Dostarlimab +Carbo/Taxol in advanced&recurrent #EndometrialCancer ✅2yr PFS dMMR 61.4% HR0.28(95%CI 0.16-0.49) ✅2yr OS dMMR 83.3% HR0.30(95%CI 0.13-0.7) ✅dMMR ORR 77.6% w durable response & well-tolerated

<a href="/MirzaCPH/">Mansoor Mirza</a> presenting practice changing Ruby trial results at #SGOmtg
✅Dostarlimab +Carbo/Taxol in advanced&amp;recurrent #EndometrialCancer
✅2yr PFS dMMR 61.4% HR0.28(95%CI 0.16-0.49)
✅2yr OS dMMR 83.3% HR0.30(95%CI 0.13-0.7)
✅dMMR ORR 77.6% w durable response &amp; well-tolerated
Pernille Bjerre Trent (@bjerretrent) 's Twitter Profile Photo

📢👏🏻🏆Congratulations to Mansoor Mirza and the #RUBYtrial team and to patients who hopefully will can benefit from #immuntherapy💉🏥🧪 in advanced #endometrialcarcinoma

📢👏🏻🏆Congratulations to <a href="/MirzaCPH/">Mansoor Mirza</a>  and the #RUBYtrial team and to patients who hopefully will  can benefit from #immuntherapy💉🏥🧪 in advanced #endometrialcarcinoma
NEJM (@nejm) 's Twitter Profile Photo

#SGOMtg: A randomized trial compared standard chemotherapy plus dostarlimab or placebo. Patients with mismatch repair–deficient tumors had 2-year progression-free survival of 61.4% with dostarlimab and 15.7% with placebo. Read full results of RUBY trial: nej.md/40lFbBN

#SGOMtg: A randomized trial compared standard chemotherapy plus dostarlimab or placebo. Patients with mismatch repair–deficient tumors had 2-year progression-free survival of 61.4% with dostarlimab and 15.7% with placebo. Read full results of RUBY trial: nej.md/40lFbBN
Annie Ellis (@stigetta) 's Twitter Profile Photo

Endometrial cancer patient @researchmatters thanks SGO for all the hard work. Standing ovation!! #SGOmtg #PatientsPurposeProgress #gyncsm

Endometrial cancer patient @researchmatters thanks <a href="/SGO_org/">SGO</a> for all the hard work. Standing ovation!! #SGOmtg #PatientsPurposeProgress #gyncsm
Mansoor Mirza (@mirzacph) 's Twitter Profile Photo

"Mansoor Mirza, MD: Ovarian Cancer Treatment and Quality of Life" ascopost.com/videos/2017-es… #oncology via @ascopost

Mansoor Mirza (@mirzacph) 's Twitter Profile Photo

ESMO 2017 Highlights in Gynaecological Cancers: Hight Quality Data From Randomised Trials - YouTube m.youtube.com/watch?v=cIEQ03…